To ensure that a patient's test is billed to their 2024 health benefits, testing must be started before the end of the year. For exome, genome, or Xpanded testing, if you do not expect parental samples to be received before the end of the year, please contact us at [email protected] to determine how to proceed.

Cerebral Cavernous Malformations (CCM) Panel


Genes

CCM2, KRIT1, PDCD10

Conditions

  • Cerebral Cavernous Malformation (CCM)

Clinical Utility

  • Confirmation of a clinical diagnosis
  • Identification of family members at-risk for cerebral cavernous malformations (CCMs)
  • Recurrence risk assessment

Lab Method

  • Capillary Sequencing
  • Deletion/Duplication Analysis

Test Code

526

CPT Codes*

81479x3

ABN Required

No

Turnaround Time**

4 weeks

Preferred Specimen

2-5 mL Blood - Lavender Top Tube

Alternative Specimen

Buccal Swabs

*The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

**Turnaround times are estimates and begin once the sample(s) begin processing at the GeneDx lab and could be extended in situations outside GeneDx’s control.